JP2016065085A5 - - Google Patents

Download PDF

Info

Publication number
JP2016065085A5
JP2016065085A5 JP2015225509A JP2015225509A JP2016065085A5 JP 2016065085 A5 JP2016065085 A5 JP 2016065085A5 JP 2015225509 A JP2015225509 A JP 2015225509A JP 2015225509 A JP2015225509 A JP 2015225509A JP 2016065085 A5 JP2016065085 A5 JP 2016065085A5
Authority
JP
Japan
Prior art keywords
compounds described
therapeutic methods
therapeutic
methods
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015225509A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016065085A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2016065085A publication Critical patent/JP2016065085A/ja
Publication of JP2016065085A5 publication Critical patent/JP2016065085A5/ja
Pending legal-status Critical Current

Links

JP2015225509A 2007-05-31 2015-11-18 モノアミン再取り込み阻害薬としてのフェニル置換シクロアルキルアミン Pending JP2016065085A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94124207P 2007-05-31 2007-05-31
US60/941,242 2007-05-31

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2013239442A Division JP2014062108A (ja) 2007-05-31 2013-11-20 モノアミン再取り込み阻害薬としてのフェニル置換シクロアルキルアミン

Publications (2)

Publication Number Publication Date
JP2016065085A JP2016065085A (ja) 2016-04-28
JP2016065085A5 true JP2016065085A5 (OSRAM) 2016-06-30

Family

ID=40094167

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2010510560A Expired - Fee Related JP5420534B2 (ja) 2007-05-31 2008-06-02 モノアミン再取り込み阻害薬としてのフェニル置換シクロアルキルアミン
JP2013239442A Withdrawn JP2014062108A (ja) 2007-05-31 2013-11-20 モノアミン再取り込み阻害薬としてのフェニル置換シクロアルキルアミン
JP2015225509A Pending JP2016065085A (ja) 2007-05-31 2015-11-18 モノアミン再取り込み阻害薬としてのフェニル置換シクロアルキルアミン

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2010510560A Expired - Fee Related JP5420534B2 (ja) 2007-05-31 2008-06-02 モノアミン再取り込み阻害薬としてのフェニル置換シクロアルキルアミン
JP2013239442A Withdrawn JP2014062108A (ja) 2007-05-31 2013-11-20 モノアミン再取り込み阻害薬としてのフェニル置換シクロアルキルアミン

Country Status (14)

Country Link
US (3) US8669291B2 (OSRAM)
EP (3) EP2154962A4 (OSRAM)
JP (3) JP5420534B2 (OSRAM)
KR (1) KR101581289B1 (OSRAM)
CN (3) CN101686672A (OSRAM)
AU (1) AU2008259841B2 (OSRAM)
BR (1) BRPI0811639A2 (OSRAM)
CA (1) CA2688493C (OSRAM)
IL (1) IL202405A (OSRAM)
MX (1) MX2009012685A (OSRAM)
NZ (1) NZ580429A (OSRAM)
RU (1) RU2470011C2 (OSRAM)
WO (1) WO2008151156A1 (OSRAM)
ZA (1) ZA200907171B (OSRAM)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004312530A1 (en) * 2003-12-29 2005-07-21 Sepracor Inc. Pyrrole and pyrazole DAAO inhibitors
CN101553217A (zh) 2005-07-06 2009-10-07 塞普拉科公司 艾司佐匹克隆与反式4-(3,4-二氯苯基)-1,2,3,4-四氢-n-甲基-1-萘胺或反式4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺的组合以及治疗绝经期和心境障碍、焦虑症和认知障碍的方法
CA2636324C (en) * 2006-01-06 2012-03-20 Sepracor Inc. Cycloalkylamines as monoamine reuptake inhibitors
US8053603B2 (en) 2006-01-06 2011-11-08 Sunovion Pharmaceuticals Inc. Tetralone-based monoamine reuptake inhibitors
AU2007233041B2 (en) 2006-03-31 2013-05-02 Sepracor Inc. Preparation of chiral amides and amines
BRPI0712823A2 (pt) 2006-06-23 2012-07-24 Abbott Lab derivados de ciclopropil amina como moduladores de receptor de histamina h3
US9108948B2 (en) 2006-06-23 2015-08-18 Abbvie Inc. Cyclopropyl amine derivatives
US7884124B2 (en) * 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7579370B2 (en) * 2006-06-30 2009-08-25 Sepracor Inc. Fused heterocycles
US20080082066A1 (en) * 2006-10-02 2008-04-03 Weyerhaeuser Co. Crosslinked carboxyalkyl cellulose fibers having non-permanent and temporary crosslinks
US7902252B2 (en) * 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
JP5420534B2 (ja) * 2007-05-31 2014-02-19 サノビオン ファーマシューティカルズ インク モノアミン再取り込み阻害薬としてのフェニル置換シクロアルキルアミン
US20100120740A1 (en) * 2008-08-07 2010-05-13 Sepracor Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
US9186353B2 (en) 2009-04-27 2015-11-17 Abbvie Inc. Treatment of osteoarthritis pain
US20110034434A1 (en) * 2009-08-07 2011-02-10 Sepracor Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
US8853390B2 (en) 2010-09-16 2014-10-07 Abbvie Inc. Processes for preparing 1,2-substituted cyclopropyl derivatives
WO2014018563A2 (en) * 2012-07-23 2014-01-30 The Board Of Trustees Of The Leland Stanford Junior University Methods for the treatment of cancer
US9126891B2 (en) * 2014-01-29 2015-09-08 MediSynergics, LLC Cycloalkyl-diamines
US9283196B1 (en) * 2013-01-30 2016-03-15 MediSynergics, LLC Cycloalkyl-diamines for CNS disorders
US9381170B2 (en) * 2013-01-30 2016-07-05 MediSynergics, LLC Cycloalkyl-diamines for neurodegenerative disorders
JP2017523967A (ja) * 2014-07-18 2017-08-24 バイエル・クロップサイエンス・アクチェンゲゼルシャフト 植物の非生物的なストレスに対する活性剤としての置換されているビニルシアノシクロアルカノール類、アルキニルシアノシクロアルカノール類、ビニルシアノヘテロシクロアルカノール類及びアルキニルシアノヘテロシクロアルカノール類
WO2017197101A1 (en) * 2016-05-12 2017-11-16 Research Triangle Institute Vinylogous phenethylamines as neurotransmitter releasers
EP4159718A4 (en) 2020-05-29 2023-10-04 Daegu-Gyeongbuk Medical Innovation Foundation SULFONAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREOF AS AN ACTIVE INGREDIENT FOR PREVENTING OR TREATING MENTAL DISEASES
JP7580849B2 (ja) 2020-05-29 2024-11-12 トリニューロ 少なくとも1つのnを含む5員ヘテロアリール誘導体、ならびにこれを有効成分として含有する精神障害の予防または治療に使用するための医薬組成物
WO2021241876A1 (ko) 2020-05-29 2021-12-02 재단법인 대구경북첨단의료산업진흥재단 카복사미드 유도체 및 이를 유효성분으로 함유하는 정신질환의 예방 또는 치료용 약학적 조성물
WO2025232878A1 (zh) * 2024-05-09 2025-11-13 苏州旺山旺水生物医药股份有限公司 一类含取代的苯基的胺类化合物、其制备方法和用途

Family Cites Families (160)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE616646A (OSRAM)
DE1124485B (de) 1960-02-12 1962-03-01 Hoechst Ag Verfahren zur Herstellung von analeptisch wirksamen Phenylcycloalkylmethylaminen
US3496181A (en) * 1966-10-24 1970-02-17 Upjohn Co 2 - aminocycloalkyl hydroquinones,esters,ethers and n-oxides thereof,and a process for preparing the same
GB1207731A (en) * 1968-05-14 1970-10-07 Reckitt & Sons Ltd Derivatives of pyrrolidine
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US3974157A (en) * 1974-03-04 1976-08-10 Pennwalt Corporation 1-(Amino-alkyl)-2-aryl-cyclohexane alcohols and esters
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4287212A (en) * 1976-04-30 1981-09-01 American Hoechst Corporation 2-Aryl-1,2-dialkylcycloalkylamines
JPS6033106B2 (ja) 1977-10-07 1985-08-01 住友化学工業株式会社 カルボン酸エステル、その製造法およびそれを有効成分とする殺虫、殺ダニ剤
ZA817261B (en) 1980-10-23 1982-09-29 Schering Corp Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them
ZA829562B (en) * 1982-02-09 1983-10-26 Upjohn Co 2-(phenylmethylene)cycloalkylamines and-azetidines
US4540690A (en) * 1982-02-09 1985-09-10 The Upjohn Company 2-(Phenylmethylene)cycloalkylamines and -azetidines
JPS58177915A (ja) 1982-04-12 1983-10-18 Green Cross Corp:The 抗血栓剤
JPS60172970A (ja) * 1984-02-15 1985-09-06 Shionogi & Co Ltd シス−アゾリルシクロアルカノ−ル誘導体およびその製造法ならびに農業用殺菌剤
EP0152032B1 (en) 1984-02-03 1988-10-26 Olympus Optical Co., Ltd. Calculus crushing apparatus
ZA855659B (en) 1984-07-30 1987-03-25 Schering Corp Novel process for the preparation of cis,endo-octahydrocyclopenta(b)pyrrole-2-carboxylate
DE3431541A1 (de) 1984-08-28 1986-03-06 Hoechst Ag, 6230 Frankfurt Cis,endo-2-azabicycloalkan-3-carbonsaeure-derivate, verfahren zu deren herstellung, deren verwendung sowie zwischenprodukte bei deren herstellung
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4738709A (en) 1985-01-10 1988-04-19 Ppg Industries, Inc. Herbicidally active substituted benzisoxazoles
US4751231A (en) 1987-09-16 1988-06-14 Merck & Co., Inc. Substituted thieno[2,3-b]pyrrole-5-sulfonamides as antiglaucoma agents
JPH01172388A (ja) 1987-12-25 1989-07-07 Sumitomo Chem Co Ltd チエノ〔3,2−b〕ピロロ〔2,3−d〕ピロール類およびその製法
US5073543A (en) 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
US4981870A (en) 1989-03-07 1991-01-01 Pfizer Inc. Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants
IT1229203B (it) 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
JPH0347123A (ja) 1989-05-05 1991-02-28 G D Searle & Co インドール―2―カルボキシレート化合物類を含有するcns疾患治療用組成物
KR100195656B1 (ko) 1989-05-31 1999-06-15 로버트 에이.아미테이지 치료학적으로 유용한 2-아미노테트랄린 유도체
US5120548A (en) 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
FI923458L (fi) 1990-02-02 1992-07-31 Schering Corp 4,5-cykloalkano-3-benzazepin-7-ol- derivat och deras anvaendning.
US5733566A (en) 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
JPH0477476A (ja) 1990-07-19 1992-03-11 Sankyo Co Ltd 抗潰瘍剤
US5086054A (en) 1990-07-31 1992-02-04 Sri International Novel arylcycloalkanepolyalkylamines
JP3007138B2 (ja) 1990-11-27 2000-02-07 ファイザー製薬株式会社 新規なヒドロキサム酸とn―ヒドロキシ尿素誘導体およびそれらの組成物
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
GB9208492D0 (en) 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
AU674358B2 (en) 1992-10-28 1996-12-19 Toyama Chemical Co. Ltd. Novel 1,2-benzoisoxazole derivative or its salt and brain -protecting agent comprising the same
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
GB9304500D0 (en) 1993-03-05 1993-04-21 Glaxo Spa Heterocyclic compounds
ES2081747B1 (es) 1993-09-07 1997-01-16 Esteve Labor Dr Amidas derivadas de tienopirroles, su preparacion y su aplicacion como medicamentos.
GB9321221D0 (en) 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds
GB9326284D0 (en) 1993-12-23 1994-02-23 Erba Carlo Spa Pyrrolydenemethyl-derivatives and process for their preparation
IT1270594B (it) 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
CN1047384C (zh) 1994-07-28 1999-12-15 北京大学 雷米普利的合成方法
WO1996006837A1 (en) 1994-08-30 1996-03-07 Sankyo Company, Limited Isoxazoles
US5484763A (en) 1995-02-10 1996-01-16 American Cyanamid Company Substituted benzisoxazole and benzisothiazole herbicidal agents
US5620997A (en) 1995-05-31 1997-04-15 Warner-Lambert Company Isothiazolones
US5859042A (en) 1995-09-27 1999-01-12 Ono Pharmaceutical Co., Ltd. Five membered heterocyclic compounds
WO1997015549A1 (en) 1995-10-26 1997-05-01 Tokyo Tanabe Company Limited PHENYLETHANOLAMINE COMPOUNDS USEFUL AS β3 AGONIST, PROCESS FOR PRODUCING THE SAME, AND INTERMEDIATES IN THE PRODUCTION OF THE SAME
HU221380B1 (en) 1996-01-31 2002-09-28 Byk Gulden Lomberg Chem Fab Phosphodiesterase inhibitor phenanthridines derivatives and use thereof
DE19711785A1 (de) 1997-03-21 1998-09-24 Merck Patent Gmbh Endothelin-Rezeptor-Antagonisten
US6503582B1 (en) 1997-08-19 2003-01-07 Mattel, Inc. Fluid-swellable composition, device and method for using the same
GB9717804D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
WO1999018065A1 (en) 1997-10-03 1999-04-15 Chirotech Technology Limited Chiral amines
GB9803226D0 (en) 1998-02-17 1998-04-08 Zeneca Ltd Chemical compounds
GB9803228D0 (en) 1998-02-17 1998-04-08 Zeneca Ltd Chemical compounds
WO1999048868A2 (en) 1998-03-26 1999-09-30 Sugen, Inc. Heterocyclic classes of compounds for the modulating tyrosine protein kinase
US6476078B2 (en) 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6632836B1 (en) 1998-10-30 2003-10-14 Merck & Co., Inc. Carbocyclic potassium channel inhibitors
HUP0104420A2 (en) * 1998-12-02 2002-08-28 Darwin Discovery Ltd Therapeutic composition containing a new form of tramadol and its use
US6828460B2 (en) * 1999-03-22 2004-12-07 Pfizer Inc. Resorcinol derivatives
DE19915601A1 (de) * 1999-04-07 2000-10-19 Gruenenthal Gmbh 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung
FR2795733B1 (fr) 1999-06-30 2001-09-07 Aventis Pharma Sa Derives de streptogramines, leur preparation et les compositions qui les contiennent
EP1391460A1 (en) 1999-09-30 2004-02-25 Pfizer Products Inc. Tricyclic pyrrolyl amides as glycogen phosphorylase inhibitors
ES2211454T3 (es) 1999-09-30 2004-07-16 Pfizer Products Inc. Pirrolilamidas como inhibidores de la colageno fosforilasa.
AU773218B2 (en) 1999-10-08 2004-05-20 Debiopharm International Sa Fab I inhibitors
DE60039631D1 (de) * 1999-12-08 2008-09-04 Lilly Co Eli Cyclopentyl sulfonamid derivaten
DE19960917A1 (de) 1999-12-17 2001-06-21 Bayer Ag Neue 3-Oxo-2,1-benzisoxazol-1(3H)-carboxamide zur Behandlung von ZNS-Erkrankungen
DE10000312A1 (de) * 2000-01-05 2001-07-12 Gruenenthal Gmbh Substituierte Aminomethyl-Phenyl-Cyclohexanderivate
JP2001247462A (ja) 2000-03-07 2001-09-11 Otsuka Pharmaceut Co Ltd ウレアーゼ阻害剤
US6632417B2 (en) 2000-03-07 2003-10-14 Chevron U.S.A. Inc. Process for preparing zeolites
EP1136071A3 (en) 2000-03-22 2003-03-26 Pfizer Products Inc. Use of glycogen phosphorylase inhibitors
WO2001079208A1 (en) 2000-04-19 2001-10-25 Kaneka Corporation Novel azetidine derivative and process for preparation thereof
GB0012214D0 (en) 2000-05-19 2000-07-12 Merck Sharp & Dohme Therapeutic agents
EP1307461A2 (en) 2000-08-04 2003-05-07 Eli Lilly And Company Substituted pyrrole compounds and their use as spla2 inhibitors
GB0021831D0 (en) 2000-09-06 2000-10-18 Astrazeneca Ab Chemical compounds
DE10049481A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte C-Cyclohexylmethylamin-Derivate
DE10049483A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte 1-Aminobutan-3-ol-Derivate
EP1330515A4 (en) 2000-10-06 2005-12-07 Affinium Pharm Inc METHOD FOR AGONIZATION AND ANTAGONIZATION OF FABK
CA2421597A1 (en) * 2000-10-13 2002-04-25 Eli Lilly And Company Cycloalkylfluorosulfonamide derivatives
SE0003810D0 (sv) 2000-10-20 2000-10-20 Pharmacia Ab Novel compounds their use and preparations
TWI283575B (en) 2000-10-31 2007-07-11 Eisai Co Ltd Medicinal compositions for concomitant use as anticancer agent
DE10063992A1 (de) 2000-12-21 2002-07-04 Max Planck Gesellschaft Tryptophan-Analoga in Proteinen, Peptiden und peptidischen Leitstrukturen
US6372919B1 (en) 2001-01-11 2002-04-16 Dov Pharmaceutical, Inc. (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent
US20020123490A1 (en) 2001-03-01 2002-09-05 Pfizer Inc. Combination treatment for anxiety, depression, obsessive compulsive disorder and psychosis
WO2003000657A1 (en) 2001-06-20 2003-01-03 Daiichi Pharmaceutical Co., Ltd. Diamine derivatives
GB0115602D0 (en) 2001-06-26 2001-08-15 Syngenta Participations Ag Organic compounds
DE10132747A1 (de) * 2001-07-05 2003-01-23 Gruenenthal Gmbh Substituierte 1-Aryl-but-3-enylamin- und 1-Aryl-but-2-enylaminverbindungen
US6603000B2 (en) 2001-07-11 2003-08-05 Boehringer Ingelheim Pharmaceuticals, Inc. Synthesis for heteroarylamine compounds
JP4331595B2 (ja) 2001-08-09 2009-09-16 第一三共株式会社 ジアミン誘導体
US7045543B2 (en) 2001-11-05 2006-05-16 Enzrel Inc. Covalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites
US20030162825A1 (en) 2001-11-09 2003-08-28 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
AU2002364517A1 (en) * 2001-11-30 2003-06-17 Sepracor Inc. Tramadol analogs and uses thereof
DE10164581A1 (de) * 2001-12-14 2003-06-26 Gruenenthal Gmbh Substituierte Aminoalkohole
DE10161809A1 (de) * 2001-12-14 2003-06-26 Gruenenthal Gmbh Arzneimittel enthaltend N,N'-disubstituierte Piperazin-Verbindungen
TW200307539A (en) 2002-02-01 2003-12-16 Bristol Myers Squibb Co Cycloalkyl inhibitors of potassium channel function
DE60327691D1 (de) * 2002-02-11 2009-07-02 Rhodia Chimie Sa Waschmittel mit blockcopolymer
GB0205170D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205165D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
US6995144B2 (en) 2002-03-14 2006-02-07 Eisai Co., Ltd. Nitrogen containing heterocyclic compounds and medicines containing the same
JPWO2003091213A1 (ja) 2002-04-25 2005-09-02 アステラス製薬株式会社 新規なアミド誘導体又はその塩
MXPA04010780A (es) 2002-05-03 2005-03-07 Warner Lambert Co Antagonistas de bombesina.
FR2841487B1 (fr) 2002-06-26 2004-08-20 Solystic Procede de detection de plis simples et de plis en prise multiple dans une installation de tri postal
DE10233048A1 (de) 2002-07-19 2004-01-29 Grünenthal GmbH Verwendung von 1-Phenyl-3dimethylamino-propanverbindungen zur Therapie von depressiven Symptomatiken
US20050182131A1 (en) * 2002-07-19 2005-08-18 Gruenenthal Gmbh 1-Phenyl-2-dimethylaminomethyl cyclohexane compounds and therapies for depressive symptoms, pain and incontinence
WO2004011459A1 (ja) 2002-07-31 2004-02-05 Mercian Corporation 新規生理活性物質
US7537891B2 (en) 2002-08-27 2009-05-26 Bristol-Myers Squibb Company Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells
US7226938B2 (en) 2002-09-06 2007-06-05 Janssen Pharmaceutica, N.V. Heterocyclic compounds
US20040087661A1 (en) 2002-09-16 2004-05-06 Sepracor, Inc. Treatment of CNS disorders with trans 4-3(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamine
NZ538741A (en) 2002-09-16 2007-01-26 Sepracor Inc Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide
TW200418838A (en) * 2002-09-18 2004-10-01 Bristol Myers Squibb Co Compounds for the treatment of premature ejaculation
JP2006504795A (ja) 2002-10-03 2006-02-09 サイプレス バイオサイエンス, インコーポレイテッド 神経学的障害を処置するための抗うつ剤の投薬量の段階的な漸増ならびに毎日の分割した投薬
GB0222909D0 (en) 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
GB0222912D0 (en) 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
US20040097554A1 (en) 2002-10-30 2004-05-20 Pfizer Inc Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents
MXPA05004968A (es) 2002-11-07 2005-08-02 Pfizer Prod Inc N-(indol-z-carbonil)amidas como agentes anti-diabeticos.
KR100998796B1 (ko) 2003-01-31 2010-12-06 가부시키가이샤산와카가쿠켄큐쇼 디펩티딜 펩티다아제 iv를 저해하는 화합물
DE602004027171D1 (de) 2003-04-11 2010-06-24 High Point Pharmaceuticals Llc Verbindungen mit Aktivität an der 11Beta-Hydroxasteroiddehydrogenase
BRPI0409952A (pt) 2003-04-30 2006-04-25 Pfizer Prod Inc agentes anti-diabéticos
WO2004113345A1 (ja) 2003-06-20 2004-12-29 Japan Tobacco Inc. 縮合ピロール化合物及びその医薬用途
PT1362864E (pt) 2003-06-30 2007-07-23 Servier Lab Novo processo de síntese do perindopril e dos seus sais aceitáveis do ponto de vista farmacêutico
AU2004255863A1 (en) 2003-07-07 2005-01-20 Ciba Specialty Chemicals Holding Inc. Process for the preparation of furopyrroles
CA2534342C (en) 2003-07-29 2016-05-10 V. Ravi Chandran Amino acid prodrugs
GB0318463D0 (en) 2003-08-07 2003-09-10 Astrazeneca Ab Chemical compounds
GB0319759D0 (en) 2003-08-22 2003-09-24 Astrazeneca Ab Chemical compounds
WO2005020986A1 (en) 2003-08-29 2005-03-10 Astrazeneca Ab Heterocyclic amide derivatives which posses glycogen phosphorylase inhibitory activity
GB0320422D0 (en) 2003-08-30 2003-10-01 Astrazeneca Ab Chemical compounds
DE602004010419T2 (de) * 2003-10-23 2008-10-09 F. Hoffmann-La Roche Ag Triazaspiropiperidinderivate zur verwendung als glyt-1-inhibitoren bei der behandlung von neurologischen und neuropsychiatrischen erkrankungen
US7396940B2 (en) 2003-10-23 2008-07-08 Hoffmann-La Roche Inc. Combinatorial library of 3-aryl-1H-indole-2-carboxylic acid
EP1420028B1 (fr) 2003-11-19 2007-02-21 Les Laboratoires Servier Pocédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables
WO2005066143A2 (en) 2003-12-29 2005-07-21 Sepracor Inc. Benzo[d]isoxazol-3-ol daao inhibitors
AU2004312530A1 (en) 2003-12-29 2005-07-21 Sepracor Inc. Pyrrole and pyrazole DAAO inhibitors
EP1746991A2 (en) 2004-03-16 2007-01-31 Janssen Pharmaceutica N.V. Daao inhibiting benzisoxazoles for treating mental disorders
PT1747210E (pt) 2004-05-07 2010-08-31 Warner Lambert Co Derivados de fenol e de tiofenol 3- ou 4-monossubstituídos úteis enquanto ligandos de h3
NZ551288A (en) * 2004-05-14 2010-10-29 Janssen Pharmaceutica Nv Carboxamido opioid compounds that are derivatives of tramadol
AU2005257859A1 (en) * 2004-05-21 2006-01-05 Merck & Co., Inc. Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity
BRPI0511504A (pt) 2004-05-26 2008-01-22 Eisai R&D Man Co Ltd composto ou um sal farmaceuticamente aceitável do mesmo, e, agente preventivo ou terapêutico para uma doença resultante de beta-amilóides
WO2005123677A1 (en) 2004-06-16 2005-12-29 Actelion Pharmaceuticals Ltd 4-carbonyl substituted 1,1,2-trimethyl-1a,4,5,5a-tetrahydro-1h-4-aza-cyclopropa'a!pentalene derivatives as agonists for the g-protein-coupled receptor s1p1/edg1 and immunosuppressive agents
JP4810426B2 (ja) 2004-07-01 2011-11-09 第一三共株式会社 Pde7阻害作用を有するチエノピラゾール誘導体
US7276631B2 (en) * 2004-07-20 2007-10-02 Bristol-Myers Squibb Company Cyclopentylamine and cyclohexylamine derivatives as NK-1/SSRI antagonists
JO2629B1 (en) 2004-08-19 2012-06-24 افينتيس فارما سوتيكالز انك Branched carboxylic acid amides containing thienobirol, carboxylic acid amides containing pyrolithiazole, and the like as kinase inhibitors casein epsilon
US7411093B2 (en) 2004-12-20 2008-08-12 Hoffman-La Roche Inc. Aminocycloalkanes as DPP-IV inhibitors
CA2594665A1 (en) 2005-01-19 2006-07-27 Biolipox Ab Thienopyrroles useful in the treatment of inflammation
CN100391945C (zh) 2005-05-31 2008-06-04 浙江大学 一种s-(-)-吲哚啉-2-羧酸的合成方法
AU2006298563A1 (en) 2005-10-06 2007-04-12 Merck & Co., Inc. Use of fused pyrrole carboxylic acids for the treatment of neurodegenerative and psychiatric diseases as D-amino acid oxidase inhibitors
UA95788C2 (en) 2005-12-15 2011-09-12 Ф. Хоффманн-Ля Рош Аг Fused pyrrole derivatives
CA2636324C (en) 2006-01-06 2012-03-20 Sepracor Inc. Cycloalkylamines as monoamine reuptake inhibitors
US8053603B2 (en) 2006-01-06 2011-11-08 Sunovion Pharmaceuticals Inc. Tetralone-based monoamine reuptake inhibitors
AU2007233041B2 (en) 2006-03-31 2013-05-02 Sepracor Inc. Preparation of chiral amides and amines
US20080058395A1 (en) 2006-06-30 2008-03-06 Sepracor Inc. Fused heterocyclic inhibitors of D-amino acid oxidase
BRPI0713216A2 (pt) 2006-06-30 2012-12-04 Sepracor Inc inibiadores heterocìclos fundidos da d-aminoácido oxidase
US7579370B2 (en) 2006-06-30 2009-08-25 Sepracor Inc. Fused heterocycles
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
CN1962656A (zh) 2006-11-29 2007-05-16 沈阳药科大学 吲哚美辛5-氟尿嘧啶甲酯药用化合物及其制剂和制备方法
CL2007003784A1 (es) 2006-12-21 2008-06-27 Abbott Lab Compuestos derivados de 1-amino-3-fenilciclopentano, que son agonistas o antagonistas de uno o mas receptores de la familia s1p; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar la esclerosis multiple, artritis reumato
US7902252B2 (en) 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
KR20090111322A (ko) 2007-01-18 2009-10-26 세프라코 아이엔시. 디 아미노산 옥시다제의 억제제
JP5420534B2 (ja) * 2007-05-31 2014-02-19 サノビオン ファーマシューティカルズ インク モノアミン再取り込み阻害薬としてのフェニル置換シクロアルキルアミン
US20100120740A1 (en) 2008-08-07 2010-05-13 Sepracor Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase

Similar Documents

Publication Publication Date Title
JP2016028092A5 (OSRAM)
JP2016065085A5 (OSRAM)
IL285650B (en) Hydroponic planter
JP2016028081A5 (OSRAM)
JP2016196495A5 (OSRAM)
JP2016502162A5 (OSRAM)
JP2017214405A5 (OSRAM)
LT3513809T (lt) Medicininė kompozicija, apimanti tivozanibą
LT3230281T (lt) 1,3-tiazol-2-ilu pakeisti benzamidai
JP2017137500A5 (OSRAM)
JP2018533683A5 (OSRAM)
KR20180084876A (ko) 내플라즈마성 부재
DK3402782T3 (da) 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decanderivater
JP2015173751A5 (OSRAM)
IL262851A (en) Combination prime: boost therapy
JP2015016294A5 (OSRAM)
JP2019505548A5 (OSRAM)
UY4430S (es) “motocicleta”.
JP2017149782A5 (OSRAM)
JP2017528459A5 (OSRAM)
JP2016053220A5 (OSRAM)
JP2016047837A5 (OSRAM)
EP3449805A4 (en) Resectoscope
JP2016054715A5 (OSRAM)
JP2015043197A5 (OSRAM)